This is consistent with the fact that ANRIL expression is significantly correlated with a higher TNM stage of cancers, including LC, GC, HCC, LSCC, OS, CRC, CC, OC, HCC, BladC and OS (Table 1). Here, CDKN2B-AS1 is linked to hepatocellular carcinoma.